Science F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy. August 26, 2026 1 minute read Read More → Post navigation Previous: Summer Weather in L.A. Was Perfect. Then Came Humidity and Mosquitoes.Next: Funeral held for renowned Palestinian artist Sliman Mansour Related Stories Science Top Mathematician Announces New Institute for A.I. Safety September 8, 2026 Science Is There Alien Debris on the Moon? Some Scientists Plan to Find Out. September 5, 2026 Science Psilocybin May Prevent Nerve Damage Caused by Chemotherapy, Study Finds September 3, 2026
